Trimunocor
Milton, United Kingdom
We have developed a novel way to produce a functional fragment of SP-D (rfhSP-D) and founded a start-up company, Trimunocor Ltd, to develop rfhSP-D into a preventive treatment for nCLD. The Aid for Start-up funding would pump prime the process development of a scale-able rfhSP-D manufacture process. If we demonstrate the commercial feasibility of manufacture, we are confident that we will secure subsequent funding from investors and pharmaceutical partners to undertake clinical trials and develop rfhSP-D as a new treatment to prevent nCLD.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2013
- Website
- www.trimunocor.com
Only accessible to MedStartr community members.
Join nowWhat do you think of Trimunocor?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now